CIG
CVS icon

Cascade Investment Group’s CVS Health CVS Stock Holding History

Cascade Investment Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,705
Closed -$216K – 135
2024
Q1 		$216K Sell
2,705
-250
-8% -$19.1K 0.16% 134
2023
Q4 		$233K Sell
2,955
-200
-6% -$14.2K 0.19% 119
2023
Q3 		$220K Sell
3,155
-1,069
-25% -$75.7K 0.21% 108
2023
Q2 		$292K Hold
4,224
– – 0.27% 92
2023
Q1 		$314K Sell
4,224
-32
-0.8% -$2.68K 0.31% 87
2022
Q4 		$397K Buy
+4,256
New +$411K 0.41% 74

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cascade Investment Group's CVS Position: Q2 2024 in Review

Cascade Investment Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,705 shares — an estimated $216K sold.

Cascade Investment Group first reported a position in CVS in Q4 2022 and held it in 6 quarters. The position peaked at $397K in Q4 2022. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Cascade Investment Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Cascade Investment Group sold 2,705 CVS Health shares in Q2 2024, an estimated $216K.
  • Cascade Investment Group first reported a position in CVS Health in Q4 2022 and held it in 6 quarters.
  • Cascade Investment Group's CVS Health position peaked at $397K in Q4 2022.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Cascade Investment Group's 13F filing for Q2 2024, filed 16 Jul 2024.